Learn More

Embolization occurs with every vascular intervention. Contego Medical's novel platform allows embolic protection with every vascular intervention.

Contego Medical's novel embolic protection devices couple angioplasty with embolic protection into a one step process.
Learn More

The Latest from Contego Medical

Contego Medical Announces Positive Clinical Data for Paladin® System, the First Post-Dilation Balloon with Integrated Embolic Protection™ Technology

Data presented at the Leipzig Interventional Course (LINC) demonstrates breakthrough treatment for Carotid Artery Disease
Raleigh, NC (January 26, 2016) — Contego Medical, an innovator in developing next generation treatments for coronary and peripheral artery disease, today presented positive post-­market registry data for the Paladin® Carotid Post-­Dilation Balloon with Integrated Embolic Protection™ (IEP) Technology at LINC 2016, in Leipzig, Germany. The presentation included compelling results from a diffusion-­weighted MRI (DW-­MRI) sub-­study that showed improved patient outcomes with the Paladin System.

Contego Medical Announces European Commercialization of the Paladin® Carotid Post-­Dilation Balloon with Integrated Embolic Protection™ Technology

Presenting at the Leipzig Interventional Course (LINC) from January 26th-­29th in Leipzig, Germany. RALEIGH, NC. (January 14, 2016) – Contego Medical today announced the European commercialization of the Paladin® Carotid Post-­Dilation Balloon, the first and only angioplasty balloon with Integrated Embolic Protection™ (IEP) Technology for patients undergoing carotid stenting procedures. The innovative IEP platform, which combines embolic protection and treatment into one device, is designed to simplify the procedure and improve patient outcomes.

About Contego Medical

Click the button to download the 2016 Contego Fact Sheet
Download Fact Sheet